Evidence map›Paper›PMID 30010796›Full record

ArticleBrain : a journal of neurology2018

A novel complex neurological phenotype due to a homozygous mutation in FDX2.

Juliana Gurgel-Giannetti, David S Lynch, Anderson Rodrigues Brandão de Paiva, Leandro Tavares Lucato, Guilherme Yamamoto, Christer Thomsen, Somsuvro Basu, Fernando Freua, Alexandre Varella Giannetti, Bruno Della Ripa de Assis and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Steroidogenic electron-transfer factors and their diseases.Annals of pediatric endocrinology & metabolism · 2021
    Article
  19. Review
  20. Imaging Patterns Characterizing Mitochondrial Leukodystrophies.AJNR. American journal of neuroradiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 6 countries.

Juliana Gurgel-GiannettiDepartment of Paediatrics, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
David S LynchDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Anderson Rodrigues Brandão de PaivaNeurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
Leandro Tavares LucatoNeuroradiology Section, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
Guilherme YamamotoHuman Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
Christer ThomsenDepartment of Pathology and Genetics, Sahlgrenska University Hospital, University of Gothenburg, Sweden.
Somsuvro BasuInstitute for Cytobiology and Cytopathology, Philipps-Universität Marburg, Robert-Koch-Strasse 6, 35032 Marburg, Germany.
Fernando FreuaNeurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
Alexandre Varella GiannettiDepartment of Surgery, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Bruno Della Ripa de AssisNeurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
Mara Dell Ospedale RibeiroNeurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
Isabella BarcelosNeurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
Katiane Sayão SouzaNeurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
Fernanda MontiNeurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
Uirá Souto MeloHuman Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
Simone AmorimNeurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
Leonardo G L SilvaHuman Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
Lúcia Inês Macedo-SouzaHuman Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
Angela M Vianna-MorganteHuman Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
Michio HiranoDepartment of Neurology, Columbia University Medical Center, New York, USA.
Marjo S Van der KnaapDepartment of Child Neurology, VU University Medical Center, Amsterdam, The Netherlands.
Roland LillInstitute for Cytobiology and Cytopathology, Philipps-Universität Marburg, Robert-Koch-Strasse 6, 35032 Marburg, Germany.
Mariz VainzofHuman Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
Anders OldforsDepartment of Pathology and Genetics, Sahlgrenska University Hospital, University of Gothenburg, Sweden.
Henry HouldenDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Fernando KokNeurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRUniversidade de São Paulo · BRPhilipps University of Marburg · DESahlgrenska University Hospital · SEUniversidade Federal de Minas Gerais · BRUniversity College London · GBAmsterdam UMC Location VUmc · NLColumbia University Irving Medical Center · US

Funding

Medical Research CouncilWellcome Trust
6 · The paper itself

Abstract

Defects in iron-sulphur [Fe-S] cluster biogenesis are increasingly recognized as causing neurological disease. Mutations in a number of genes that encode proteins involved in mitochondrial [Fe-S] protein assembly lead to complex neurological phenotypes. One class of proteins essential in the early cluster assembly are ferredoxins. FDX2 is ubiquitously expressed and is essential in the de novo formation of [2Fe-2S] clusters in humans. We describe and genetically define a novel complex neurological syndrome identified in two Brazilian families, with a novel homozygous mutation in FDX2. Patients were clinically evaluated, underwent MRI, nerve conduction studies, EMG and muscle biopsy. To define the genetic aetiology, a combination of homozygosity mapping and whole exome sequencing was performed. We identified six patients from two apparently unrelated families with autosomal recessive inheritance of a complex neurological phenotype involving optic atrophy and nystagmus developing by age 3, followed by myopathy and recurrent episodes of cramps, myalgia and muscle weakness in the first or second decade of life. Sensory-motor axonal neuropathy led to progressive distal weakness. MRI disclosed a reversible or partially reversible leukoencephalopathy. Muscle biopsy demonstrated an unusual pattern of regional succinate dehydrogenase and cytochrome c oxidase deficiency with iron accumulation. The phenotype was mapped in both families to the same homozygous missense mutation in FDX2 (c.431C > T, p.P144L). The deleterious effect of the mutation was validated by real-time reverse transcription polymerase chain reaction and western blot analysis, which demonstrated normal expression of FDX2 mRNA but severely reduced expression of FDX2 protein in muscle tissue. This study describes a novel complex neurological phenotype with unusual MRI and muscle biopsy features, conclusively mapped to a mutation in FDX2, which encodes a ubiquitously expressed mitochondrial ferredoxin essential for early [Fe-S] cluster biogenesis.

Indexed as

AdolescentAdultBrazilChildElectron Transport Complex IVExome SequencingFemaleFerredoxinsHomozygoteHumansIronIron-Sulfur ProteinsLeukoencephalopathiesMaleMitochondriaMitochondrial ProteinsElectron Transport Complex IVFerredoxinsIronIron-Sulfur ProteinsMitochondrial ProteinsSuccinate Dehydrogenase

Identifiers

PMID30010796
PMCPMC6061701
OpenAlexW2883825773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.